InvestorsHub Logo
Followers 0
Posts 59
Boards Moderated 0
Alias Born 06/22/2015

Re: None

Wednesday, 08/24/2016 9:32:38 AM

Wednesday, August 24, 2016 9:32:38 AM

Post# of 4962
NTCHF:

NEWS! New Viritron Patent Filed with USPTO
The company recently filed a new Viritron patent.
Viritron VPN is a new biopharmaceutical aimed at the
bacteria that causes Pneumonia.
http://www.otcmarkets.com/stock/NTCHF/news/N1-Technologies-Patents-VIRITRON-VPN-Pneumonia-Treatment?id=139141&b=y


N1 Technologies moving forward with leading lab
The company announcing it is working with a leading Biophage
research lab, Phage Consultants located in Poland. Both
companies to team up on the research and development of
the Viritron VDX and Viritron VPN biopharmaceuticals.